← Eichor
Study identifier: NCT04898114 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

Condition: Persistent Pulmonary Hypertension of Newborn  ·  Sponsor: Sohag University

PhasePhase 1/Phase 2
Planned participants40
Who can joinAll sexes, 6 Hours to 72 Hours
Healthy volunteersNo

About this study

The aim of this study is to evaluate the effectiveness of nebulized magnesium sulfate combined with sildenafil citrate, compared with sildenafil citrate alone, in treating neonates with severe persistent pulmonary hypertension on mechanical ventilation.

This description comes directly from the study's public registry record.

Talk to the study team

Elsayed Abdelkreem, MD, PhD  ·  00201114232126  ·  d.elsayedmohammed@med.sohag.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Neonatal Intensive Care Unit, Sohag University HospitalSohag, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04898114